Vardenafil Dihydrochloride
"Vardenafil Dihydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A piperazine derivative, PHOSPHODIESTERASE 5 INHIBITOR and VASODILATOR AGENT that is used as a UROLOGICAL AGENT in the treatment of ERECTILE DYSFUNCTION.
Descriptor ID |
D000069058
|
MeSH Number(s) |
D03.383.129.308.980 D03.383.606.960
|
Concept/Terms |
Vardenafil- Vardenafil
- 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
Vardenafil Hydrochloride- Vardenafil Hydrochloride
- Hydrochloride, Vardenafil
- Vardenafil Hydrochloride Anhydrous
- Anhydrous, Vardenafil Hydrochloride
- Hydrochloride Anhydrous, Vardenafil
|
Below are MeSH descriptors whose meaning is more general than "Vardenafil Dihydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Vardenafil Dihydrochloride".
This graph shows the total number of publications written about "Vardenafil Dihydrochloride" by people in this website by year, and whether "Vardenafil Dihydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vardenafil Dihydrochloride" by people in Profiles.
-
Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus? PLoS One. 2018; 13(6):e0199299.
-
Time of onset of vardenafil orodispersible tablet in a real-life setting - looking beyond randomized clinical trials. Expert Rev Clin Pharmacol. 2017 Mar; 10(3):339-344.
-
Effectiveness of Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction in Patients with Spinal Cord Trauma: Systematic Review and Meta-Analysis. Urol Int. 2017; 98(2):198-204.
-
Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013 May; 63(5):902-12.